Neuromyelitis Optica Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Neuromyelitis Optica?
Neuromyelitis optica (NMO), now more commonly called neuromyelitis optica spectrum disorder (NMOSD), is a rare autoimmune disorder that affects the central nervous system, particularly the optic nerves and spinal cord. NMOSD can cause episodes of optic neuritis, transverse myelitis and other neurological syndromes, potentially resulting in vision loss, muscle weakness, sensory disturbances or bladder and bowel problems. Early diagnosis is important because NMOSD requires a different treatment approach from multiple sclerosis and other demyelinating disorders.
What is the Importance of Timely Treatment?
NMOSD attacks can cause substantial neurological damage and may result in persistent disability if not treated promptly. Early recognition of optic neuritis, transverse myelitis or other characteristic symptoms allows doctors to begin acute treatment and reduce inflammation as quickly as possible. Long-term preventive therapy may also be required because recurrent attacks can accumulate neurological disability. Accurate diagnosis is particularly important because some treatments used for multiple sclerosis may be inappropriate or potentially harmful in NMOSD.
What are the Common Symptoms of an Neuromyelitis Optica?
- Eye pain, particularly with eye movement
- Blurred or reduced vision, often affecting one or both eyes
- Loss of colour vision
- Partial or severe vision loss
- Limb weakness or paralysis
- Numbness, tingling or altered sensation
- Painful muscle spasms
- Difficulty walking or maintaining balance
- Loss of bladder or bowel control
- Nausea and persistent or unexplained vomiting
- Persistent or severe hiccups
- Facial weakness or other brainstem symptoms
- Symptoms related to inflammation in the brain or other central nervous system regions
Causes and Risk Factors of Neuromyelitis Optica
Causes
- NMOSD is primarily an autoimmune disorder in which the immune system attacks components of the central nervous system. In many patients, antibodies against aquaporin-4 (AQP4-IgG) contribute to inflammation and astrocyte injury.
- Some patients who have an NMOSD-like clinical presentation do not have detectable AQP4-IgG and may require additional evaluation, including testing for myelin oligodendrocyte glycoprotein antibodies (MOG-IgG), because MOG-associated disease is a distinct condition that can overlap clinically with NMOSD.
Risk Factors
- Female sex, particularly in AQP4-IgG-positive disease
- Presence of AQP4-IgG antibodies
- Personal or family history of autoimmune disorders
- Coexisting autoimmune conditions
- Previous NMOSD attack
- Certain genetic and immune-system factors
- MOG-IgG positivity in patients with a different demyelinating disease phenotype
Latest Research and Technologies in the Treatment of Neuromyelitis Optica in India
- Research in NMOSD increasingly focuses on biomarker-guided diagnosis, relapse prevention and targeted immune therapies. Cell-based AQP4-IgG testing can improve diagnostic accuracy, while MRI of the optic nerves, brain and spinal cord helps identify characteristic patterns of inflammation. Research continues into biomarkers that may predict disease activity, treatment response, and long-term disability, as well as improved therapies for AQP4-IgG-negative disease.
Treatment options for Neuromyelitis Optica
Plasma Exchange : Plasma exchange may be used when a severe attack responds inadequately to corticosteroids or when rapid removal of pathogenic antibodies is required. Immunoadsorption may be available at selected specialist centres.
Cost Start From 450Explore Options
Targeted Therapies : For AQP4-IgG-positive NMOSD, targeted therapies include complement inhibition and B-cell-directed therapy with receptor blockade. Regulatory indications and availability vary between countries.
Cost Start From 1000Explore Options
- Clinical assessment:
- Neurological Evaluation: A detailed neurological examination assesses vision, eye movements, muscle strength, reflexes, sensation, coordination, gait and bladder or bowel function. The history focuses on the timing and pattern of attacks, previous neurological episodes, recovery between attacks and associated symptoms such as persistent vomiting or hiccups.
- AQP4-IgG Antibody Testing: Serum AQP4-IgG testing is an important component of NMOSD evaluation. Cell-based assays are preferred when available because they provide improved sensitivity and specificity compared with some older testing methods.
- MOG-IgG Testing: Consider MOG-IgG testing, particularly in AQP4-IgG-negative patients or when clinical and imaging features suggest MOG-associated disease.
- Cerebrospinal Fluid Assessment: Lumbar puncture may be performed in selected patients to analyse cerebrospinal fluid and help distinguish NMOSD from infections, multiple sclerosis and other inflammatory or neurological disorders.
- Visual and Neurophysiological Assessment: Visual acuity, colour vision, visual fields, optical coherence tomography and visual evoked potentials may help evaluate optic nerve involvement and establish a baseline for monitoring visual function.
- Imaging Tests:
- MRI of the Brain: Helps identify lesions affecting the brainstem, area postrema, diencephalon and other characteristic regions and helps exclude alternative diagnoses.
- MRI of the Spinal Cord: Particularly important for evaluating transverse myelitis. Longitudinally extensive spinal cord lesions involving multiple vertebral segments are characteristic of NMOSD, although shorter lesions can also occur.
- MRI of the Optic Nerves: Helps identify optic neuritis, including lesions involving long segments of the optic nerve or optic chiasm.
- Contrast-Enhanced MRI: May demonstrate active inflammation and help assess disease activity.
- Optical Coherence Tomography: Provides detailed assessment of retinal nerve-fibre and ganglion-cell layers and may help monitor structural effects of optic neuritis.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Neuromyelitis Optica patients in India. These services include:
- Physiotherapy and Strength Training: Physiotherapy can help maintain muscle strength, flexibility, balance and mobility after spinal cord or other neurological involvement.
- Gait and Mobility Rehabilitation: Patients with leg weakness, balance problems or spasticity may receive gait training, transfer training and appropriate assistive-device support.
- Vision Rehabilitation: Patients with persistent visual impairment may benefit from low-vision assessment, visual aids, environmental adaptations and training to improve independence.
- Bladder, Bowel and Functional Rehabilitation: Occupational and rehabilitation specialists can help patients manage bladder or bowel dysfunction, transfers, self-care and activities of daily living.
- Psychological and Long-Term Support: Counselling, patient education and fatigue-management strategies can help patients cope with a chronic neurological condition, recurrent attacks and changes in independence or daily functioning.
- Medicines for NMOSD are used to control acute attacks and reduce the risk of future relapses. High-dose corticosteroids are commonly used during acute attacks, while plasma exchange may be added for severe attacks or inadequate steroid response. Long-term relapse prevention may involve conventional immunosuppressive medicines or targeted biological therapies for appropriate patients. These medicines require specialist monitoring for infections, laboratory abnormalities and other treatment-specific risks.
Instantly Connect with our Specialists
Hospitals for Neuromyelitis Optica in India
The Medical Park
Chennai, India
The Medical Park, located in the heart of Chennai, is a leading one-stop wellness and aesthetic surgery center, specializing in both surgical and non-surgical treatments. With over 25 years of expertise in aesthetic procedures, The Medical Park is renowned for its commitment to providing high-quality, patient-centric care. The clinic offers a wide range of services designed to promote overall health, rejuvenation, and well-being, combining state-of-the-art facilities with advanced medical technology.
The Medical Park in Chennai is a premier healthcare and wellness facility that offers a comprehensive range of services designed to promote overall well-being. Combining state-of-the-art medical treatments with a holistic approach to health, their clinic provides a one-stop solution for those seeking aesthetic procedures, wellness programs, and mental health support. The Wellness Centre is equipped with the latest fitness technologies and staffed by highly trained professionals.
Manipal Hospital, Dwarka
Delhi, India
Manipal Hospital Dwarka is a leading multi-super speciality tertiary care hospital offering world-class, affordable, and accessible healthcare. Backed by renowned doctors, advanced technology, and global standards in clinical care, the hospital provides comprehensive preventive, diagnostic, and therapeutic services for all age groups. With 380 beds, 13 modular OTs, 118 critical care beds, and 24/7 emergency services, it combines excellence in patient care with innovations like AI, telemedicine, remote monitoring, and EMR—striving to become a fully digital, paperless hospital setting new standards in modern healthcare.
Artemis Health Institute
Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Neuromyelitis Optica Treatment?
- Multidisciplinary Neurological Care: Patients can access neurologists, neuroimmunology specialists, neuro-ophthalmologists, rehabilitation physicians, and other specialists as needed.
- Advanced Diagnostic Facilities: Specialised centres may provide AQP4-IgG and MOG-IgG testing, MRI of the brain, optic nerves and spinal cord, CSF analysis and neurophysiological assessments.
- Acute Attack Management: Major neurological centres can provide high-dose corticosteroids, plasma exchange and intensive monitoring for severe NMOSD attacks.
- Targeted Immunotherapy: Eligible patients may be evaluated for conventional immunosuppressive treatment and targeted biological therapies based on antibody status and clinical characteristics.
- Comprehensive Rehabilitation and International Patient Support: Physiotherapy, vision rehabilitation, occupational therapy, psychological support and international-patient coordination can be incorporated into the treatment pathway.